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Diabetes mellitus, a complex chronic pathological 
condition, is considered a major health problem 
worldwide. This metabolic disorder is characterized by 
hyperglycemia and disturbances in carbohydrate, protein, 
and fat metabolisms secondary to an absolute or relative 
lack of insulin (1). Besides hyperglycemia, several other 
factors including dyslipidemia or hyperlipidemia are 
involved in the development of micro- and macrovascular 
complications of diabetes, leading to morbidity and 
mortality (2). For Algerian practitioners, diabetes 
is considered a serious public health problem since, 
according to the World Health Organization, 10% of the 
Maghreb inhabitants were diagnosed with type-2 (non-
insulin-dependent) diabetes, with 24.1 million persons 
affected. Insulin therapy and other conventional drugs 
are not devoid of adverse side effects in addition to their 
unsatisfactory efficiency in certain cases, which urges the 
quest for the development of more effective antidiabetic 
natural agents. In fact, previous studies confirmed the 
efficiency of several medicinal plants in diabetes (3,4). 
Another therapeutic approach for treating diabetes is to 
inhibit the carbohydrate-hydrolyzing enzymes such as 
α-amylase, thus retarding the absorption of glucose in the 
digestive tract. 
Liver disease constitutes another endemic problem in 
the world, causing the death of about 25,000 people annually 
due to liver cirrhosis caused by hepatitis (5) and lesions 
due to injury by free radical derivatives of paracetamol 
(6). Since the latter generates lipid peroxidation, the 
inhibition of the generation of free radicals is important in 
the protection against paracetamol-induced hepatopathy 
(7). In this perspective, natural antioxidants may play a 
key role in hepatoprotection. However, even though there 
is an increased assumption that natural products are safe, 
scientific studies have shown that several phytochemicals 
Background/aim: The present study was designed to explore antidiabetic and hepatoprotective potentials of Fraxinus angustifolia leaf 
(FAL) and bark (FAB) extracts in vivo. 
Materials and methods: Streptozotocin (STZ)-induced diabetic rats, pretreated with the extracts (25 and 50 mg/kg), were monitored 
for fasting blood glucose (FBG) levels. Hepatoprotective potential was examined after injection of an excessive dose of paracetamol (10 
g/60 kg) by analysis of biochemical parameters (transaminases, bilirubin), malondialdehyde (MDA) levels, and histological sections. 
high performance liquid chromatography analysis was also performed for partial characterization.
Results: A considerable hypoglycemic effect was noticed 2 h after the STZ-induction, with a higher efficiency (P < 0.05) for FAL (68%) 
as compared with FAB (57%). A significant (P < 0.05) reduction in MDA was observed for paracetamol-fed mice pretreated with 
FAL (50 mg/kg), FAB (50 mg/kg), or both (25 mg/kg each) extracts, and the MDA levels for the three conditions were 0.290 ± 0.034, 
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can be cytotoxic, genotoxic, and carcinogenic when 
consumed excessively and irrationally (8). The toxicity 
of medicinal plants depends on many factors such as the 
part of plant and the extraction solvent used, which will 
determine the composition and biological activity of the 
extracts as well as the bioavailability of their components. 
Moreover, poor handling of raw or processed materials 
may produce exogenous toxic contaminants, not inherent 
as plant phytochemicals (9). 
In recent years, several authors investigated the 
antidiabetic potential of Algerian medicinal plants using 
experimental animals (10,11). Some species of Fraxinus 
have been examined for their hypoglycemic potential (12), 
but no data are available concerning Fraxinus angustifolia. 
The leaves and bark of this tree, endemic in Northwestern 
Africa, are traditionally used as diuretic, antirheumatoid, 
laxative, sudoriﬁc (13), hypotensive, hypoglycemic, and 
antiseptic (14–16). Therefore, the aim of the present study 
was to examine in vivo the subchronic toxicity and the 
antidiabetic and hepatoprotective potentials of ethanolic 
extracts of F. angustifolia. In order to understand the 
mechanism of antidiabetic action, the α-amylase activity of 
the extracts was also tested. Moreover, high performance 
liquid chromatography (HPLC) profiles of the extracts 
were established and compared with standards for partial 
characterization.
2. Materials and methods
2.1. Preparation of plant extracts
Fresh leaves and barks of F. angustifolia were harvested from 
Tizi Neftah, a remote place in the Province of Amizour, 
Bejaia, northeastern Algeria. The plant was identified in 
the Laboratory of botany (University of Bejaia) where a 
specimen was deposited. The leaves and barks were air-
dried in the shade and ground to fine powders (63 µm 
in diameter); they were extracted separately with ethanol 
(1/4: w/v) at room temperature for 24 h. The extractive 
liquids were evaporated to obtain dry crude hydroalcoholic 
extracts of Fraxinus angustifolia leaves (FAL) and Fraxinus 
angustifolia bark (FAB).
2.2. HPLC fractionation and analysis
Extracts of FAB and FAL (3 g) were fractionated by HPLC 
with a photodiode array detector (HPLC-DAD) (pf 425–
250 Interchim, C8 column Zorbax, 150 × 21.5 mm (250 
bars)) at a concentration of 100 g/L. The mobile phase 
consisted of methanol (A) and water (B) with the following 
elution gradient: 0 min 0% A 100% B, 26.0 min 100% A 0% 
B; 26.1–29.4 0% A 100% B, 29.4–29.5 0% A 100% B. The 
flow rate was 20 mL/min and the column temperature was 
set at 25 °C. 
Chemical characterization of FAL and FAB extracts was 
carried out by comparing the detected polyphenol peaks 
with respect to retention times with those of standard 
chemicals (such as chlorogenic acid, tyrosol, benzoic 
acid, caffeic acid, vanillic acid, syringic acid, sinapic acid, 
ferulic acid, oleuropein, quercetin, luteolin, cinnamic acid, 
and apigenin) that were monitored at 250 nm using the 
same HPLC system. All standards were purchased from 
Extrasynthese or Sigma-Aldrich. Identity and purity of the 
chemical standards were assessed by HPLC analysis. 
2.3. Laboratory animals 
Albino male mice (25 ± 3 g) and Wistar rats of either 
sex weighing 180–220 g obtained from Pasteur Institute 
(Algiers, Algeria) were provided with standard food and 
water ad libitum; the animals were kept in a constant 
controlled environment (temperature of 23 ± 1° C, relative 
humidity of 65 ± 5%, and 12/12 h light/dark cycle). After 
two weeks of acclimatization to laboratory conditions, 
experiments were conducted in strict compliance 
with internationally accepted principles for work with 
laboratory animals (directive N° 2010/63/EU of 22 
September 2010, which updates and replaces directive N° 
86/609/EEC of 24 November 1986).
2.4. Determination of total polyphenols and flavonoids
The quantification of total polyphenols was conducted 
according to the Folin–Ciocalteu procedure (17), using 
catechin as a standard. First, 0.1 mL of extract (3.1 mg/mL 
in methanol), 0.5 mL of Folin–Ciocalteu (1/10) reagent, 
and 1.5 mL of Na2CO3 (20%) were mixed. After incubation 
for 1 h, absorbance was measured at 765 nm. Results were 
expressed as mg of catechin equivalents per gram of extract 
obtained from a regression curve. Flavonoid content was 
determined using a colorimetric method (18) with some 
modifications. Then 1 mL of extract (0.15 mg/mL in 
methanol) was mixed with 0.5 mL of AlCl3 and incubated 
for 10 min, after which the absorbance was measured at 
430 nm. Results were calculated as mg rutin equivalents 
per gram of extracts obtained from a regression curve.
2.5. Subchronic toxicity
Twenty-five Wistar male rats were randomized into 5 
groups (n = 5) and administered orally daily doses of the 
following solutions: group I received physiological saline 
(0.9%); groups II and III received FAL and FAB extracts at 
20 mg/kg, respectively; and groups IV and V were given 
FAL and FAB extracts at 200 mg/kg, respectively. Rats were 
weighted on a daily basis and observations were made 
twice daily for mortality and changes in general behavior. 
At the end of the experiment (28 days), mice were 
anesthetized, sacrificed, and blood samples were collected 
for determination of hematological and biochemical 
parameters. 
2.6. Antidiabetic activity in vivo
Diabetes was induced in Wistar rats fasted overnight by 
an intraperitoneal injection of 60 mg/kg of a solution 
of streptozotocin (STZ) (Sigma). Rats that developed 
glycemia with glucose levels higher than 200 mg/dL 72 
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h after STZ injection (19) were preselected and assigned 
to 6 groups (n = 5): group I (control) received vehicle 
(physiological saline 0.9%); group II received a reference 
molecule, Diabenil (50 mg/kg); groups III and IV received 
FAL and FAB extracts (25 mg/kg) respectively, and groups 
V and VI received FAL and FAB extracts (50 mg/kg), 
respectively. The volume of the suspension administered 
was based on body weight measured immediately prior to 
each dose (10 mL/kg). Blood withdrawn from the retro–
orbital sinuses of the eyes was collected in heparinized 
tubes, after 1 and 2 h of treatment. Recovered blood 
was then centrifuged at 1500 × g for 10 min for glucose 
measurements using SPINREACT kit (cat. no-1001191). 
2.7. α-Amylase inhibition assay
α-Amylase inhibition by FAL and FAB extracts was 
assessed using the method of Hasenah et al. (20). First, 
400 µL of substrate solution prepared by using potato 
starch (0.5%) in phosphate buffer (20 mM, pH 6.9) and 
containing sodium chloride (6.7 mM) was mixed with 40 
µL of plant extract (75–250 µg/mL) and 160 µL of distilled 
water. The enzymatic reaction was initiated by the addition 
of 200 µL of Aspergillus oryzae α-amylase (4 units/mL) 
(Sigma Aldrich) followed by incubation for 3 min at 25 
°C. Subsequently, 200 µL of the reaction mixture was 
added to 100 µL (96 mM) 3,5-dinitrosalicylic acid sodium 
potassium tartrate (5.31 M) dissolved in NaOH (2 M) and 
incubated at 85 °C for 15 min. After addition of 900 µL 
of distilled water, the absorbance was measured at 540 
nm. Enzyme inhibition was calculated using the following 
formula: % inhibition = [1 – (At/Ac)] × 100, where At and 
Ac are absorbances of the test solutions with and without 
extract, respectively.
2.8. Hepatoprotective potential
The hepatoprotective effect of F. angustifolia ethanol 
extracts against paracetamol-induced toxicity was 
investigated using the method of Yeh and Hu (21). Forty 
male albino mice (25 ± 2 g) were randomly allocated to 
control and test groups (n = 8) in the following manner: 
group I (negative control) received saline solution (0.9%); 
group II (positive control) received an oral overdose of 
paracetamol (10 g/60 kg) on day 1 and serum saline (0.9%) 
on days 2 and 3; groups III, IV, and V were administered 
paracetamol (10 g/60 kg) on day 1 and FAL (50 mg/kg), 
FAB (50 mg/kg), and a mixture of both (25 mg/kg of each), 
respectively, on days 2 and 3.
2.8.1. Estimation of biochemical parameters
At the end of the experiment, mice were anesthetized and 
sacrificed. Blood samples were collected from their retro–
orbital sinus and their livers were removed for further 
analysis. Blood samples were allowed to clot and sera 
were separated by centrifugation (2500 × g, 37 °C), stored 
at –20 °C until use for determination of the following 
hematological and biochemical parameters: transaminases 
(aspartate transaminase (AST) (cat.no-HBE06), alanine 
transaminase (ALT) (cat.no-HBE07), and total bilirubin) 
using commercial kits (Cypress Diagnostics).
2.8.2. Lipid peroxidation assay
Mice livers were excised promptly, weighed, and washed 
thoroughly in cold saline (0.9%). One gram of liver was 
chopped into 4–5 volumes of Tris buffer (0.15 M, pH 
7.4) and homogenized. Lipid peroxidation was assayed 
according to standard procedures (22). Briefly, 1 mL 
of normal saline and 2 mL of 10% trichloroacetic acid 
(TCA) were added to 1 mL of tissue homogenate, and the 
mixture was centrifuged (3000 × g, 10 min). Then 2 mL 
of the obtained supernatant were removed, to which 0.5 
mL of thiobarbituric acid (TBA) (1%) was added followed 
by heating at 100 °C for 30 min. The absorbance of the 
samples was measured at 532 nm and the MDA levels 
were expressed as nmoles MDA/mg of liver tissue using 
the extinction coefficient 1.56 × 105 M–1 cm–1 (23).
2.8.3. Histological analysis
Liver tissues isolated previously were fixed in 10% formalin 
solution. Paraffin blocks were prepared after completing the 
tissue processing in different grades of alcohol and xylene. 
Sections (4 µm) were prepared from paraffin blocks using 
a microtome and stained with hematoxylin and eosin. 
Microscopic examinations were conducted to detect signs 
of liver damage such as necrosis (neutrophil infiltration 
and dilatation of sinusoids), steatoses (fat deposits), and 
dilatation and congestion of the centrilobular vein. 
3. Statistical analysis
Results were expressed as means ± standard deviation 
for in vitro tests or standard error of the means (SEM) 
for in vivo tests. Experimental data were analyzed using 
GraphPad Prism 5.3 software. Analysis of variance 
(ANOVA) was used, followed by Dunnett’s test. The results 
were considered statistically significant at *P < 0.05, **P < 
0.01, and ***P < 0.001.
4. Results 
4.1. HPLC analysis
HPLC analysis of bark and leaf extracts (Figure 1) showed 
profiles with retention times that coincided exactly with 
some of these chemicals. Mainly, for bark, retention times 
of fractions 1, 2, 6, and 8 coincided with tyrosol, caffeic 
acid, pinoresinol, and luteolin, respectively. For leaves, 
retention times of fractions 1, 2, and 3 were found identical 
to those of oleuropein, quercetin, and cinnamic acid. 
4.2. Determination of total polyphenols and flavonoids
Data shown in Table 1 indicate the presence of a substantial 
amount of polyphenols in the FAB extract compared with 
its FAL counterpart, while a greater amount of flavonoids 
was found in the FAL than in the FAB extract. 
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Figure 1. A) Chromatogram of standards: 1: chlorogenic acid; 2: tyrosol; 3: benzoic acid; 4: caffeic acid; 5: vanillic acid; 
6: syringic acid; 7: sinapic acid; 8: ferulic acid; 9: oleuropein; 10: quercetin; 11: luteolin; 12: cinnamic acid; 13: apigenin. 
B) Chromatogram of F. angustifolia leaf extract: F1: oleuropein; F2: cinnamic acid; F3: quercetin. C) HPLC chromatogram 
of F. angustifolia bark extract: E1: tyrosol; E2: caffeic acid; E6: pinoresinol; E8: luteolin.
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4.3. Subchronic toxicity
Indications of toxicity are alterations in clinical signs such 
as diarrhea, weight loss, agitation, hispid hair, convulsions, 
tremors, dyspnea, and mortality (24). The close monitoring 
of mice during the whole treatment period indicated no 
such toxicity signs. Moreover, compared with the control 
group, no significant loss or gain of weight for any of the 
tested groups was observed during or at the end of the 28 
days experiment (Figure 2).
No change in AST activity was observed in mice treated 
with either FAL (81.5 ± 3.8 and 79.0 ± 3.3 IU/L at 20 and 
200 mg/kg, respectively) or FAB (77.0 ± 3.8 and 72.7 ± 2.1 
IU/L at 20 and 200 mg/kg, respectively). Nevertheless, with 
respect to ALT, considered to be more specifically related 
to liver problems, a slight and dose-dependent toxicity was 
recorded in mice treated with FAL (45.5 ± 1.8 IU/L), while 
FAB (28.2 ± 1.9 IU/L) (200 mg/kg) reduced significantly 
the level of this enzyme (Table 2). At the same time, total 
bilirubin was unchanged with FAB (0.73 ± 0.07 mg/
mL), but showed dose-dependent decreased levels with 
FAL (0.56 ± 0.04 mg/mL) (Table 3). In addition, blood 
sugar (1.03 ± 0.05 and 1.11 ± 0.04 g/L for FAL and FAB, 
respectively) or cholesterol levels (0.51 ± 0.03 g/L; 0.44 ± 
0.04 g/L for FAL and FAB, respectively) were not affected 
(Table 3), while creatinine was either not altered for FAL at 
20 mg/kg (9.80 ± 0.74 mg/mL) or significantly (P < 0.05) 
reduced for FAL at 200 mg/kg (4.16 ± 0.17 mg/mL) and for 
FAB at 200 mg/kg (4.06 ± 0. 35 mg/mL).
4.4. Antidiabetic activity
4.4.1. Antidiabetic activity in vivo
Induction of diabetes in experimental rats was conﬁrmed 
by a considerable rise in fasting blood glucose (FBG) levels 
(> 150 mg/dl) for the diabetic control rats (Figure 3). On 
the other hand, FAL reduced FBG by 45% and 68% at 25 
Table 1. Determination of total polyphenols and flavonoids in Fraxinus angustifolia leaf and bark extracts.
Total polyphenols
mg Eq catechin/g extract
Total flavonoids
mg Eq rutin/g extract







FAL: F. angustifolia leaves; FAB: F. angustifolia bark.




















Table 2. Effect of prolonged administration (28 days) of F. angustifolia leaf and bark ethanol extracts on mean (± SEM) serum enzyme 
parameters.
Groups AST IU/L ALT IU/L ALP IU/L
I 73.0 ± 2.8a 31.6 ± 1.8b 236.0 ± 3.3b
II 81.5 ± 3.8c 39.0 ± 2.3c 234.0 ± 7.1b
III 77.0 ± 3.8ab 33.6 ± 2.6b 456.6 ± 6.9d
IV 79.0 ± 3.3ab 45.5 ± 1.8d 296.6 ± 10.3c
V 72.7 ± 2.1a 28.2 ± 1.9a 152.0 ± 3.8a
IU/L: International unit/L.  AST: aspartate amino transferase. ALT: alanine amino transferase. ALP: alkaline phosphatase G-I: Control, 
G-II: FAL 20 mg/kg, G-III: FAB 20 mg/kg, G-IV: FAL 200 mg/kg, G-V: FAB 200 mg/kg. Each value in the table is the mean ± (SEM) (n 
= 6). Values in the same column sharing different letters are significantly different (P < 0.05) (ANOVA followed by Newman–Keuls).
Figure 2. Bodyweight gain after 28 experimental days. FAL: 
Fraxinus angustifolia leaves, FAB: Fraxinus angustifolia bark. I: 
Control, II: FAL 20 mg/kg, III: FAB 20 mg/kg, IV: FAL 200 mg/
kg, V: FAB 200 mg/kg. All values are expressed as means ± SEM 
of six animals. One-way ANOVA followed by Dunnett’s test was 
used for statistical signiﬁcance. *P < 0.05, compared with the 
normal control group.
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and 50 mg/kg, respectively, compared to 26% and 57% 
at the same respective doses for FAB. Diabenil (50 mg/
kg), a well-known antidiabetic drug, caused a significant 
(P < 0.01) decrease of blood glucose (72%) after 2 h of 
treatment, comparable (P > 0.05) with that of FAL at 50 
mg/kg. 
4.4.2. Antidiabetic activity in vitro: α-amylase inhibition 
assay
In the α-amylase inhibition assay, the extracts exerted 
a moderate, dose-dependent inhibition on this enzyme 
(IC50 values of 187.42 and 360.75 µg/mL for FAL and FAB, 
respectively) (Figure 4), significantly (P < 0.05) lower than 
that of the standard acarbose (IC50 = 15.87 µg/mL). 
4.5. Hepatoprotective potential
In order to estimate if liver necrosis was prevented by F. 
angustifolia extracts after paracetamol treatment, three 
parameters were evaluated: plasma transaminases, MDA 
levels, and liver histology. 
4.5.1. Blood parameters 
Paracetamol significantly (P < 0.05) raised hepatic 
enzyme levels (AST = 241.83 ± 67.33 IU/L, ALT = 66.66 
± 15.25 IU/L) and total bilirubin (1.41 ± 0.40 mg/mL) 
in the positive control group (Table 4, group II). While 
the FAB extract (50 mg/kg) failed to protect liver cells, 
the FAL extract led to a significant (P < 0.05) decrease in 
transaminase levels (AST = 200.20 ± 35.89 IU/L; ALT = 
Tablea3. Effect of prolonged administration (28 days) of F. angustifolia ethanol leaf and bark extracts on mean (± SEM) biochemical 
parameters.
Groups Creat mg/mL Glc g/L Chol g/L TBil mg/mL
I 8.60 ± 0.48d 1.01 ± 0.09 ab 0.47 ± 0.08ab 1.10  ± 0.15c
II 9.80 ± 0.74d 1.03 ± 0.05ab 0.59 ± 0.05c 1.02 ± 0.23c
III 4.94 ± 0.30b 1.11 ± 0.04b 0.42 ± 0.04a 0.73 ± 0.07b
IV 4.16 ± 0.17a 1.026 ± 0.03ab 0.51 ± 0.03bc 0.56 ± 0.04ab  
V 4.06±0. 35a 0.98±0.12a 0.44±0.04ab 0.61 ± 0.25a   
Creat: creatinine, Glc: glucose, Chol: cholesterol, TBil: Total bilirubin, G-I: Control, G-II: FAL 20 mg/kg, G-III: FAB 20 mg/kg, G-IV: 
FAL 200 mg/kg, G-V: FAB 200 mg/kg. Each value in the table is the mean ± (SEM) (n = 6). Values in the same column sharing different 
letters are significantly different (P < 0.05). (ANOVA followed by Newman–Keuls).

























Figure 3. Percent decrease of glucose after the first and second 
hour of treatment. FAL: F. angustifolia leaves; FAB: F. angustifolia 
barks. All values are expressed as means ± SEM of six animals. 
One-way ANOVA followed by Dunnett’s test was used for 






























Figure 4. Percent inhibition of α-amylase by Fraxinus angustifolia 
ethanolic leaf and bark extracts. FAL: Fraxinus angustifolia 
leaves. FAB: Fraxinus angustifolia bark. All values are expressed 
as means ± SEM of six animals. One-way ANOVA followed by 
Dunnett’s test was used for statistical signiﬁcance. *P < 0.05, **P 
< 0.01, ***P < 0.001 compared with the acarbose group.
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63.98 ± 9.45 IU/L for group III and AST = 236.94 ± 27.45 
IU/L; ALT = 84.34 ± 12.53 IU/L for group IV) (Table 
4). Moreover, FAL extract prevented liver damage much 
better than the combined treatment of 25 mg/kg of each 
extract (FAB and FAL) (AST = 208.54 ± 48.63 IU/L; ALT 
= 71.01 ± 17.22 IU/L) (Table 4, group V). On the other 
hand, total bilirubin level was restored to its normal level 
completely and equally by all the treatments (1.42 ± 0.35 
mg/mL for FAL; 0.79 ± 0.08 mg/mL for FAB and 0.85 ± 
0.14 mg/mL for FAL/FAB). 
4.5.2. Lipid peroxidation assay
MDA is a widely used marker of free radical-mediated lipid 
peroxidation, which explains why a significant increase 
(P < 0.05) of MDA (0.45 ± 0.040 nmol/mg liver tissue) in 
paracetamol-induced mice was observed compared with 
the negative control group (0.12 ± 0.07 nmol/mg liver 
tissue) (Figure 5). On the other hand, an ameliorative effect 
on the MDA levels (P < 0.05) in groups pretreated with FAL 
or FAB extracts (0.290 ± 0.034 and 0.340 ± 0.038 nmol/
mg liver tissue) was noticed. Simultaneous treatment with 
both extracts provided even a better hepatoprotective effect 
(MDA = 0.250 ± 0.058 nmol/mg liver tissue) (Figure 5). 
4.5.3. Histological analysis
Signs of extensive damage in livers of paracetamol-treated 
mice were obvious in the histological sections of the 
positive control group with massive centrilobular necrosis 
(leucocytes infiltration around the centrilobular veins) 
and some periportal degeneration (Figure 6). However, 
FAL and FAB provided significant protection against 
paracetamol-induced damage as the centrilobular area 
(i.e. the area in which covalent binding of paracetamol is 
preferentially localized) showed only little degeneration 
(Figures 6C and 6D). However, less protection was 
observed with the simultaneous treatment with both 




The present HPLC system was able to detect all the 
standards as the respective simple peaks with good 
resolution (Figure 1A). The most remarkable observation 
from this data is that leaf and bark extracts do not share 
common chemicals and that all of the compounds with 
the exception of luteolin in bark were previously detected 
in this species (25,26). Moreover, the occurrence of 
secoridoids such as oleuropein and phenylethanoids such 
as tyrosol is a characteristic feature of Fraxinus species 
(26). 
5.2. Determination of total polyphenols and flavonoids
Fraxinus angustifolia is a widely used shrub in folk 
medicine in Algeria. Its healing virtues are related to its 
high content of natural compounds, mainly polyphenols, 
Table 4. Effect of F. angustifolia ethanol leaf and bark extracts on serum enzyme levels after treatment with paracetamol (10 g/60 kg).
Groups AST  IU/L ALT  IU/L TBil mg/mL
I 78.90 ± 9.30a 59.5 ± 9.41a 0.95 ± 0.48a
II 241.83 ± 67.33c 66.66  ± 15.25ab 1.41 ± 0.40b
III 200.20 ± 35.89cd 63.98 ± 9.45a 1.42 ± 0.35a
IV 236.94 ± 27.45d 84.34 ± 12.53b 0.79 ± 0.08a
V 208.54 ± 48.63b 71.01 ± 17.22ab 0.85 ± 0.14a
IU/L: International unit/L.  AST: aspartate amino transferase, ALT: alanine amino transferase, TBil  : total bilirubin, G-I: Control-, 
G-II: paracetamol group 10 g/60 kg, G-III: FAL 50 mg/kg, G-IV: FAB 50 mg/kg, G-V: FAL/FAB 50 mg/kg. Each value in the table is the 






























Figure 5. Malondialdehyde (MDA) levels in mice pretreated 
with F. angustifolia ethanol leaf and bark extracts. FAL: Fraxinus 
angustifolia leaves, FAB: Fraxinus angustifolia barks. All values 
are expressed as means ± SEM of six animals. One-way ANOVA 
followed by Dunnett’s test was used for statistical signiﬁcance. *P 
< 0.05, **P < 0.01, ***P < 0.001 compared with the control group.
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which have been previously quantified (7,27). The results 
obtained in those studies are in full agreement with our 
findings. Additionally, the Fraxinus genus is described as a 
rich source of flavones and flavonols that are derivatives of 
quercetin and kaempferol (26). The above HPLC analysis 
confirmed the presence of a flavone, luteolin, and a 
flavonol, quercetin, in FAB and FAL extracts, respectively. 
5.3. Subchronic toxicity
The extent of hepatic injury is assessed by the level of 
released cytoplasmic enzymes, AST and ALT, in circulation 
(28,29). The unaltered activity of AST, ALT, or bilirubin for 
both FAL- and FAB-fed mice (except for a slight rise in ALT 
in FAL-treated mice) (45.5 ± 1.8 IU/L) confirmed that the 
treatment did not cause hepatocellular injury. In addition, 
as revealed by glucose, cholesterol, and creatinine data, 
the extracts did not disrupt sugar or lipid metabolisms 
and did not cause impairment of kidney function. Aside 
from the interest in the efficacy of medicinal plant extracts 
against various diseases, safety (short and long term) is an 
important factor in traditional medicine. This experiment 
showed that the long-term administration of both parts of 
F. angustifolia did not present any toxicity. 
5.4. Antidiabetic activity
5.4.1. Antidiabetic activity in vivo
The rise in glucose levels in the control positive group was 
counteracted by a maximal hypoglycemic effect in the test 
Figure 6. Histological sections of liver (400×). A) Untreated control group.   B) Group supplemented with 10 g/60 kg of 
paracetamol: inflammatory mass, massive necrosis (B1), centrilobular veins dilated and congested (B2), dilated sinusoids.
C) Group treated with 50 mg/kg of FAL, conserved architecture centrilobular vein dilated, no necrosis. D) Group treated with 
50 mg/kg FAB conserved architecture with some necrosis. E) Group treated with leaves/barks extract, some necrosis.
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groups, which was observed more specifically in 2 h, and 
more so in the case of FAL compared with FAB treatment. 
No previous data about the antidiabetic activity of F. 
angustifolia was reported, but findings on a related species, 
Fraxinus excelsior (12), were less promising because a 
single oral administration of an aqueous extract (20 mg/
kg) of this plant reduced blood glucose levels from the 
1st (P < 0.01) to the 6th h (P < 0.001) by only 13.6% in 
diabetic rats. The cytotoxic activity of STZ on pancreatic 
cells is based on the prooxidant action mechanism of STZ, 
acting as an NO. donor and causing the fragmentation of 
DNA (30). Therefore, we assume that the high tolerance 
to glucose observed can be attributed to the antioxidant 
activity of the constituent flavonoids of F. angustifolia 
as higher amounts of these compounds in leaves led to 
higher protective activity against the toxic impact of 
STZ compared with that of the bark. The antioxidant 
potential of F. angustifolia bark extract was demonstrated 
in previous studies (27,31). Moreover, the current study 
revealed the presence of a number of phytochemicals that 
constitute a major group of compounds that act as primary 
antioxidants with high redox potentials and singlet 
oxygen quenchers (32). Some of these compounds, such 
as quercetin and luteolin, have shown strong antidiabetic 
activities (33), which corroborates earlier investigations 
that equally established a close relationship between the 
antioxidant properties of polyphenolic compounds and 
their antidiabetic potential (34,35).
5.4.2. Antidiabetic activity in vitro: α-amylase inhibition 
assay
Pancreatic α-amylase catalyzes the initial step in the 
hydrolysis of starch, a principal source of glucose in the 
diet (36). Therefore, the inhibition of this enzyme by FAL 
and FAB extracts would prevent more glucose release 
in the blood. The higher inhibition by FAL over FAB 
extract observed consolidates the above findings of the 
in vivo experiment in which the FAL extract was a more 
potent hypoglycemic agent than its bark counterpart. 
Moreover, this assay helped to gain some insight on the 
possible mechanism of action of F. angustifolia extracts 
by revealing that they contain α-amylase inhibitory 
metabolites, although other mechanisms cannot be 
excluded. In fact, past clinical studies have demonstrated 
that phenolic compounds, such as luteolin, that inhibit 
carbohydrate-hydrolyzing enzymes decrease postprandial 
hyperglycemia in noninsulin-dependent diabetes mellitus 
patients; however, it was less potent than acarbose (37).
5.5. Hepatoprotective potential
Paracetamol-induced hepatic injury is a commonly used 
experimental model for the screening of hepatoprotective 
drugs (38,39). The lesions produced are the result of 
the prooxidant effect of paracetamol, affecting blood 
parameters. 
5.5.1. Blood parameters 
The deleterious effect of paracetamol provoked an increase 
in transaminase levels, in agreement with previous 
findings (40), as a result of induced acute toxicity and 
destruction of liver cells. The administration of the FAL 
extract contributed to restoring the transaminase enzyme 
activities to their normal level, which was not the case 
for the FAB extract, which was insufficient to prevent the 
damage to liver cells by paracetamol. 
5.5.2. Lipid peroxidation assay
Paracetamol is converted in the liver into its reactive 
metabolite N-acetyl [-p-benzo quinine imine] by hepatic 
cytochrome P-450 (40–42), leading to massive production 
of reactive species and depletion of protective physiological 
moieties such as glutathione and α-tocopherol. This 
ultimately leads to lipid peroxidation, which causes damage 
to the macromolecules in vital biomembranes (43,44), 
generating necrosis. Our experiment demonstrated that FAL 
was more efficient than FAB extracts in attenuating the MDA 
levels (produced as a result of lipid peroxidation). However, 
a more prominent effect was observed with simultaneous 
treatment, demonstrating a synergistic action between 
the compounds of both parts of the plant. HPLC analysis 
revealed the presence of some strong antioxidant compounds 
in both extracts such as caffeic acid and luteolin in bark and 
quercetin in leaves. However, limited information about the 
bioactive molecule responsible for the observed synergistic 
effect makes its identification imperative and even interesting. 
Indeed, knowledge of the molecular structures would help 
us gain insight into the mechanisms involved and widen 
the perspective of their exploitation in the pharmacological 
industry. Moreover, this route constitutes another research 
interest of our team in our continuous quest for identification 
of natural substances from local medicinal plants. For now, 
we can only assume that the counteracting effects of F. 
angustifolia against paracetamol toxicity may be due to the 
antioxidant potential of the extracts of this plant reported 
in an earlier in vitro study (25). The above data revealing 
higher quantity of flavonoids in FAL than in FAB may be 
an additional proof that the antioxidant character of the leaf 
constituents may lie behind their enhanced activity over FAB 
against reactive species generated by paracetamol. Patients 
with diabetes mellitus are characterized with elevated levels 
of oxidative damage and decreased levels of antioxidant 
defenses, and are prone to lipid abnormalities due to lipid 
peroxidation (45). Oxidative stress puts diabetes patients at 
high risk for the development of coronary disease and renal 
and liver failures. Treatment strategies that rely on insulin 
or Diabenil do not offer an antioxidant machinery to fight 
the prooxidant diseases that are associated with diabetes. 
Therefore, natural remedies of antioxidant character are good 
candidates to fight diabetes and associated problems, keeping 
in mind their lack of secondary effects that are common in 
modern drugs.
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5.5.3. Histological analysis
The analysis of liver histology concluded that less necrosis 
and damage were generated in the extract-treated groups, 
and especially in those receiving FAL, compared with 
the control group. These results confirmed the above 
findings related to MDA and transaminase levels, with the 
exception of the group treated with both parts of the plant. 
The results of studies on the mechanism of hepatic necrosis 
suggest that lesion genesis proceeds in a sequence of events 
(46,47). The first can be metabolic activation of a toxic 
reactive intermediate as in the case of paracetamol. The 
latter might be irreversible destruction of cell components 
leading to disturbances in essential biochemical processes. 
This means that protection by F. angustifolia extracts 
against paracetamol-induced hepatotoxicity might involve 
inhibition of oxidative formation and/or detoxification of 
the paracetamol reactive metabolite. The high antioxidant 
capacities of the extracts (26) are probably implicated in 
those mechanisms. 
In conclusion, the present work demonstrated that 
leaf and bark extracts of F. angustifolia are safe for use in 
folk medicine. It also shed light on their antidiabetic and 
hepatoprotective potentials, revealing higher activities 
for leave extracts than for their bark counterparts, which 
can be accounted for by their higher flavonoid content. 
The antioxidant power of flavonoids are surely implicated 
in the hepatoprotective potential of the plant and 
partially involved in its hypoglycemic action since other 
mechanisms, such as the inhibition of α-amylase, can 
play a considerable role. Therefore, F. angustifolia extracts 
might be considered for use in association with insulin 
therapy to alleviate the adverse side effects caused by that 
drug. 
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